常山酮基于调控自噬抵抗衰老作用和机制的研究
批准号:
82060267
项目类别:
地区科学基金项目
资助金额:
34.0 万元
负责人:
吴沁翼
依托单位:
学科分类:
衰老相关疾病
结题年份:
2024
批准年份:
2020
项目状态:
已结题
项目参与者:
吴沁翼
中文摘要
衰老与许多衰老性疾病的发生和发展关系密切。衰老在挑战个人、家庭和社会经济和心理负担能力的同时,更是一个现今医学界面临急需解决的难题。衰老,其本质是衰老细胞的累积,提示清除和减少衰老细胞的累积或成为抗击衰老研究的主要方向。自噬作为一种高保守的降解机制,能有效的减少和抑制衰老细胞的产生和累积,然而自噬水平在衰老模型中出现了明显的下降,通过上调衰老时期的自噬水平有效的延缓衰老疾病和运动功能障碍的发生和发展,提示上调自噬水平或可成为抗击衰老的重要机制。常山酮是一种从中药常山中分离得到的喹唑啉酮生物碱,其作用机制因细胞类型或细胞内的信号环境不同而出现显著差异。我们前期的研究发现,常山酮能通过上调自噬水平显著延长线虫的寿命,然而常山酮在抗击衰老过程中的作用和机制则需要更加深入的研究,且迄今为止国内外尚未有类似的研究报道。本项目拟从细胞、线虫和小鼠中探索常山酮上调自噬延缓衰老的能力和作用机制
英文摘要
Aging is considered to associate with various types of senile diseases, including cancer, hypertension, diabetes, cardiovascular disease, arthritis, chronic obstructive pulmonary, Alzheimer's disease and Parkinson's disease, the manifestation and progression of which show a positive correlation with age. Nowadays, senescence still remains a challenge to modern medical science, not only because of heavy finance and mentality burden pushed upon individual, family and society, but also causing diseases together with psychological problems which are contradicted with the expectance of health life expansion and high quality of elderly lives. Fundamentally, the accumulation of senescent cells laid the ground of senescence which refers to an irreversible process involving the degradation and disturbance of multi-tissues and multi-organ function, suggesting clearance and reduction of senescent cells may be becoming the target of anti-aging research. Autophagy is a highly conservative degradation mechanism, can effectively reduce and inhibit the generation and accumulation of senescent cells, however, previous researches showed the level of autophagy decline following with aging, suggesting rising the autophagy level may be the key mechanism to combat aging in turn to delay the occurrence and development of age-related diseases. Halofuginone is a quinazoline alkaloid isolated from Chinese herb Dichroa febrifuga Lour. Surprisingly, the function of halofuginone differs significantly from cell to cell depending on the cell types or environments within the cell. Our research found that halofuginone significantly extends the lifespan of C.elegans by increasing the level of autophagy. However, the target and mechanism of halofuginone regard to autophagy level rising still require more detailed research. This project intends to explore the ability and mechanism of halofuginone to up-regulate autophagy resulting in anti-aging effects through an experiment designed in mammalian cells, C.elegans and mice.
本研究通过体外细胞实验、线虫动物模型和小鼠模型系统地探讨了常山酮在延缓衰老方面的作用及其潜在机制。首先,我们发现在人胚肺成纤维细胞IMR90的持续传代过程中,衰老标志物β-半乳糖甘酶(SA-β-gal)的水平随代数增加而升高。然而,给予常山酮处理后,SA-β-gal水平较对照组显著降低,表明常山酮可减缓细胞衰老。同样,在线虫中,常山酮的摄入显著延长了寿命,并减缓了运动能力和应激耐受能力的下降。此外,在急性衰老小鼠模型中,常山酮改善了骨骼肌病理变化,延缓了运动和代谢能力的衰退,证实其抗衰老作用。进一步研究表明,常山酮通过上调自噬延缓细胞、线虫和小鼠的衰老。在IMR90细胞中,使用自噬抑制剂巴佛洛霉素A1处理后,常山酮诱导的自噬水平被抑制,SA-β-gal水平升高。在线虫中,沉默自噬相关基因后,常山酮对线虫衰老的延缓作用消失。同样,在小鼠模型中,给予自噬抑制剂氯喹后,常山酮改善骨骼肌病理变化和运动能力的作用消失,进一步表明常山酮通过促进自噬发挥其抗衰老效应。RNA-seq转录组分析发现,常山酮处理后,应激相关的基因显著上调,其中部分基因为DAF-16的下游靶基因。在急性衰老小鼠模型中,常山酮上调转录因子FOXO3a的靶基因表达,使用抑制剂辛伐他汀后,常山酮对自噬的上调及其抗衰老作用均被阻断。此外,在筛选延长线虫寿命的七条信号通路后,我们发现常山酮通过mTOR通路上调自噬并延长寿命,该作用依赖于自噬调控因子HLH-30。同样,在小鼠模型中,使用mTOR激动剂MYH1485处理后,常山酮对自噬的上调及其改善骨骼肌病理变化、运动能力和代谢能力的作用均被逆转。此外,常山酮能够提高线虫AMPK的磷酸化水平,从而增加自噬并延长寿命。在AMPK(AAK-2)和mTOR(LET-363)缺失的线虫中,常山酮延长寿命的作用消失,进一步表明其依赖AMPK/mTOR通路发挥作用。综上所述,本研究通过细胞、线虫和小鼠模型系统地证明了常山酮的抗衰老作用,并揭示其通过AMPK/mTOR信号通路上调自噬以延缓衰老的分子机制。这些研究结果为常山酮作为潜在抗衰老干预剂提供了理论依据。
国内基金
海外基金